Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format
Year: 2020
Type: article
Abstract: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are commercially available, and cardiac differentiation established routine. Systematic evaluation of several control hiPSC-CM is lacking. We investigated 10 different control hiPSC-CM lines and analyzed function and suitability for drug screening. Five commercial and 5 academic hPSC-CM lines were casted in engineered heart tissue (EHT) format. Spontaneous and stimulated EHT contractions were analyzed, and 7 inotropic indicator compounds investigated on 8 cell lines. Baseline contractile force, kinetics, and rate varied widely among the different lines (e.g., relaxation time range: 118-471 ms). In contrast, the qualitative correctness of responses to BayK-8644, nifedipine, EMD-57033, isoprenaline, and digoxin in terms of force and kinetics varied only between 80% and 93%. Large baseline differences between control cell lines support the request for isogenic controls in disease modeling. Variability appears less relevant for drug screening but needs to be considered, arguing for studies with more than one line.
Source: Stem Cell Reports
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,800
Funders: Deutsches Zentrum für Herz-Kreislaufforschung, British Heart Foundation, Heart Research UK, National Centre for the Replacement, Refinement and Reduction of Animals in Research, Deutsche Forschungsgemeinschaft, Technische Universität München, BIRAX, Medical Research Council, Engineering and Physical Sciences Research Council, European Research Council
Awards: G1288996096, MICA: Development of Metrics and Quality Standards for Scale up of Human Pluripotent Stem Cells, G1640917251, G1809243133, G2196526216, G3020690360, G3418652168, G3681226940, G5119768880, Human cardiomyocytes from pluripotent stem cells to study β-adrenoceptor signaling (renewal), G7162305877, Deep molecular phenotyping of myotonic dystrophy (DM1) hiPSC-cardiomyocytes to facilitate risk stratification and drug evaluation, G7531635858, G7670758531, Coupling gene targeted reporters with fully automated compound library screening to mature hPSC-cardiomyocytes
OpenAlex ID: W3093465023
